Conning Inc’s Avanos Medical AVNS Stock Holding History

Conning Inc’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,164	Closed	-$205K	–	576
2015 Q1	$205K	Buy	+4,164	New	+$193K	0.01%	560

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

RR Partners New York $929M AUM 110.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Conning Inc's AVNS Position: Q2 2015 in Review

Conning Inc sold out of Avanos Medical (AVNS) in Q2 2015, closing a stake of 4,164 shares — an estimated $205K sold.

Conning Inc first reported a position in AVNS in Q1 2015 and held it in 1 quarter. The position peaked at $205K in Q1 2015. 419 funds tracked by Wall St. Rank hold AVNS as of Q2 2015.

Conning Inc reported no remaining Avanos Medical position as of Q2 2015 after selling out during the quarter.
Conning Inc sold 4,164 Avanos Medical shares in Q2 2015, an estimated $205K.
Conning Inc first reported a position in Avanos Medical in Q1 2015 and held it in 1 quarter.
Conning Inc's Avanos Medical position peaked at $205K in Q1 2015.
419 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2015.

Based on Conning Inc's 13F filing for Q2 2015, filed 3 Aug 2015.